Drug Name: | Ticagrelor |
---|
Drug Class: | Antiplatelet agent |
---|
Mechanism of Action: | - Reversibly binds to the P2Y12 receptor on platelets, preventing ADP-mediated activation and subsequent platelet aggregation
|
---|
Use: | - Prevention of thrombotic events in patients with acute coronary syndrome (ACS), including unstable angina (UA), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI)
|
---|
Side Effects: | - Bleeding
- Dyspnea
- Bradycardia
- Headache
- Nausea
|
---|
Contraindications: | - Active bleeding
- History of intracranial hemorrhage
- Severe hepatic impairment
|
---|
Specialty: | - Cardiology
- Emergency Medicine
- Critical Care
|
---|